# EDGAR Filing Document

**Accession Number:** 0001484565
**File Stem:** 0001873522-26-000006
**Filing Date:** 2026-3
**Character Count:** 8505
**Document Hash:** bb0f93f56becb694c75142c872cbb499
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001873522-26-000006.hdr.sgml**: 20260304

**ACCESSION NUMBER**: 0001873522-26-000006

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260302

**FILED AS OF DATE**: 20260304

**DATE AS OF CHANGE**: 20260304

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Fulk Jennifer
- **CENTRAL INDEX KEY:** 0001873522

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36593
- **FILM NUMBER:** 26723141

**MAIL ADDRESS:**
- **STREET 1:** C/O SOLENO THERAPEUTICS, INC.
- **STREET 2:** 100 MARINE PARKWAY, SUITE 400
- **CITY:** REDWOOD CITY
- **STATE:** CA
- **ZIP:** 94065
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SOLENO THERAPEUTICS INC
- **CENTRAL INDEX KEY:** 0001484565
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 770523891
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 100 MARINE PARKWAY, SUITE 400
- **CITY:** REDWOOD CITY
- **STATE:** CA
- **ZIP:** 94065
- **BUSINESS PHONE:** 650-213-8444

**MAIL ADDRESS:**
- **STREET 1:** 100 MARINE PARKWAY, SUITE 400
- **CITY:** REDWOOD CITY
- **STATE:** CA
- **ZIP:** 94065

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Capnia, Inc.
- **DATE OF NAME CHANGE:** 20100219

## Ex-24

POWER OF ATTORNEY

Know all by these present, that the undersigned hereby constitutes and appoints each of

Anish Bhatnagar and Jesse Schumaker signing singly, the undersigned's true and lawful attorney-in-

fact to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) execute for and on behalf of the undersigned, in the undersigned's capacity as an

officer and/or director of Soleno Therapeutics Inc. (the "Company"), Schedules 13D

and 13G, Form ID, and Forms 3, 4 and 5 and amendments thereto in accordance with

Section 13 and/or Section 16(a) of the Securities Exchange Act of 1934, as amended

(the "Exchange Act"), and the rules thereunder, and Form 144 and amendments

thereto in accordance with Rule 144 promulgated under the Securities Act of 1933, as

amended (the "Securities Act");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) do and perform any and all acts for and on behalf of the undersigned which may be

necessary or desirable to complete and execute any such Schedules 13D and 13G,

Form ID, Form 144, and Forms 3, 4 and 5 and amendments thereto and timely file

such form with the United States Securities and Exchange Commission and any stock

exchange or similar authority; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) take any other action of any type whatsoever in connection with the foregoing which,

in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or

legally required by, the undersigned, it being understood that the documents executed

by such attorney-in-fact on behalf of the undersigned pursuant to this Power of

Attorney shall be in such form and shall contain such terms and conditions as such

attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do

and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the

exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the

undersigned might or could do if personally present, with full power of substitution or revocation,

hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or

substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights

and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in

serving in such capacity at the request of the undersigned, are not assuming, nor is the Company

assuming, any of the undersigned's responsibilities to comply with Sections 13 and Section 16 of the

Exchange Act, or Rule 144 promulgated under the Securities Act. The undersigned hereby agrees to

indemnify the attorney-in-fact and the Company from and against any demand, damage, loss, cost or

expense arising from any false or misleading information provided by the undersigned to the

attorney-in-fact.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer

required to file any Schedules 13D and 13G, and Forms 3, 4 and 5 in accordance with Sections 13

and/or 16(a) of the Exchange Act, and Form 144 in accordance with Rule 144 promulgated under the

Securities Act, with respect to the undersigned's holdings of and transactions in securities issued by

------

the Company, unless earlier revoked by the undersigned in a signed writing delivered to the

foregoing attorneys-in-fact. This Power of Attorney may be filed with the United States Securities

and Exchange Commission as a confirming statement of the authority granted herein. This Power of

Attorney supersedes any prior power of attorney in connection with the undersigned's capacity as an

officer and/or director of the Company. This Power of Attorney shall expire as to any individual

attorney-in-fact if such attorney-in-fact ceases to be an executive officer of, or legal counsel to the

Company.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be

executed as of February 18, 2026.

<u>/s/ Jennifer Fulk</u>

Signature

Print Name:

<u>Jennifer Fulk</u>

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Fulk Jennifer<br><sub>(Last) (First) (Middle)</sub><br>100 MARINE PARKWAY, SUITE 400<br><sub>(Street)</sub><br>REDWOOD CITY, CA 94065<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>SOLENO THERAPEUTICS INC [ SLNO ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-03-02 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_CHIEF FINANCIAL OFFICER_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |

---

**Remarks:**
Exhibit 24 - Power of Attorney

**Signature:** /s/ Anish Bhatnagar, Attorney-in-Fact  
**Date:** 2026-03-04

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**